X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9282) 9282
Magazine Article (23) 23
Book Chapter (13) 13
Book / eBook (3) 3
Newspaper Article (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Newsletter (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (9139) 9139
humans (9051) 9051
uterine cervical neoplasms - drug therapy (4832) 4832
adult (3633) 3633
middle aged (3544) 3544
oncology (3507) 3507
cervical cancer (3449) 3449
uterine cervical neoplasms - pathology (3323) 3323
cancer (2592) 2592
aged (2325) 2325
uterine cervical neoplasms - radiotherapy (1759) 1759
obstetrics & gynecology (1632) 1632
chemotherapy (1460) 1460
antineoplastic combined chemotherapy protocols - therapeutic use (1279) 1279
neoplasm staging (1179) 1179
carcinoma (1163) 1163
carcinoma, squamous cell - drug therapy (1163) 1163
animals (1121) 1121
uterine cervical neoplasms - therapy (1111) 1111
combined modality therapy (1104) 1104
uterine cervical neoplasms - metabolism (1093) 1093
treatment outcome (1082) 1082
radiotherapy (1076) 1076
hela cells (1011) 1011
uterine cervical neoplasms - surgery (1009) 1009
care and treatment (987) 987
cisplatin (987) 987
cisplatin - administration & dosage (967) 967
apoptosis (966) 966
cell line, tumor (917) 917
antineoplastic agents - therapeutic use (881) 881
uterine cervix (836) 836
prognosis (823) 823
uterine cervical neoplasms - genetics (807) 807
health aspects (797) 797
mice (779) 779
research (755) 755
human papillomavirus (736) 736
uterine cervical neoplasms - virology (720) 720
apoptosis - drug effects (707) 707
male (696) 696
carcinoma, squamous cell - pathology (684) 684
analysis (666) 666
hysterectomy (660) 660
uterine cervical neoplasms - mortality (659) 659
women (656) 656
expression (651) 651
retrospective studies (637) 637
cervix (633) 633
squamous-cell carcinoma (624) 624
risk factors (614) 614
uterine cervical neoplasms - diagnosis (595) 595
hematology, oncology and palliative medicine (582) 582
tumors (581) 581
radiation-therapy (551) 551
antineoplastic agents - pharmacology (543) 543
obstetrics and gynecology (541) 541
surgery (522) 522
chemotherapy, adjuvant (521) 521
follow-up studies (502) 502
adenocarcinoma - drug therapy (498) 498
aged, 80 and over (491) 491
cell proliferation - drug effects (490) 490
radiology, nuclear medicine & medical imaging (483) 483
carcinoma, squamous cell - radiotherapy (479) 479
therapy (478) 478
disease-free survival (470) 470
pharmacology & pharmacy (462) 462
survival (460) 460
survival rate (454) 454
cisplatin - therapeutic use (447) 447
uterine cervical neoplasms - prevention & control (447) 447
papillomavirus infections (432) 432
young adult (431) 431
pregnancy (424) 424
gynecologic-oncology-group (422) 422
metastasis (421) 421
antineoplastic agents - administration & dosage (419) 419
dose-response relationship, drug (419) 419
time factors (419) 419
antineoplastic combined chemotherapy protocols - adverse effects (411) 411
adolescent (402) 402
neoplasm recurrence, local - drug therapy (398) 398
uterine cervical neoplasms - epidemiology (398) 398
prospective studies (395) 395
medicine & public health (391) 391
neoadjuvant chemotherapy (388) 388
proteins (376) 376
survival analysis (375) 375
diagnosis (370) 370
drug therapy (363) 363
biochemistry & molecular biology (362) 362
cell biology (361) 361
neoadjuvant therapy (357) 357
drug administration schedule (354) 354
adenocarcinoma - pathology (347) 347
cancer therapies (347) 347
ovarian neoplasms - drug therapy (347) 347
risk (340) 340
cell survival - drug effects (337) 337
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8590) 8590
Japanese (317) 317
German (187) 187
Russian (123) 123
French (111) 111
Chinese (96) 96
Italian (51) 51
Spanish (36) 36
Bulgarian (26) 26
Polish (25) 25
Portuguese (16) 16
Czech (13) 13
Dutch (7) 7
Hungarian (6) 6
Ukrainian (5) 5
Danish (4) 4
Swedish (4) 4
Finnish (3) 3
Korean (3) 3
Norwegian (3) 3
Romanian (3) 3
Bosnian (2) 2
Croatian (2) 2
Hebrew (2) 2
Serbian (2) 2
Arabic (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of radiation oncology, biology, physics, ISSN 0360-3016, 11/2017, Volume 99, Issue 4, pp. 1039 - 1047
Journal Article
Cancer letters, ISSN 0304-3835, 2007, Volume 251, Issue 1, pp. 132 - 145
.... Therefore, we tested the in vitro sensitivity of broad cell line panels derived from lung, colorectal, breast, prostate and cervical cancer, which are the prevalent cancer types characterized... 
Hematology, Oncology and Palliative Medicine | Chemotherapy | Lung cancer | Betulinic acid | Colorectal cancer | Breast cancer | Prostate cancer | Cervical cancer | Apoptosis | ACTIVATION | colorectal cancer | INDUCED APOPTOSIS | breast cancer | apoptosis | TUMOR-CELLS | betulinic acid | IDENTIFICATION | cervical cancer | chemotherapy | CYTOTOXIC ACTIVITY | lung cancer | prostate cancer | ONCOLOGY | HUMAN-MELANOMA CELLS | SERINE-PROTEASE | INDUCED DEATH | INHIBITOR | DERIVATIVES | Neoplasms - metabolism | Lung Neoplasms - drug therapy | Prostatic Neoplasms - metabolism | Triterpenes - pharmacology | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Uterine Cervical Neoplasms - metabolism | Colorectal Neoplasms - drug therapy | Female | Colorectal Neoplasms - metabolism | Prostatic Neoplasms - drug therapy | Cell Survival - drug effects | Prostatic Neoplasms - pathology | Jurkat Cells | Cells, Cultured | Uterine Cervical Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Blotting, Western | Neoplasms - drug therapy | Poly(ADP-ribose) Polymerases - metabolism | Breast Neoplasms - pathology | Cell Line, Tumor | Antineoplastic Agents, Phytogenic - pharmacology | Colorectal Neoplasms - pathology | Neoplasms - pathology | Cancer
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 8, pp. 734 - 743
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2014, Volume 40, Issue 6, pp. 770 - 780
Abstract Although anti-HER2 (human epidermal growth factor receptor 2) therapy is currently approved for breast, gastric, and gastroesophageal cancers overexpressing the HER2 protein or amplified for the HER2 gene, HER2 aberrations... 
Hematology, Oncology and Palliative Medicine | Human epidermal growth factor 2 | Pertuzumab | Afatinib | Target therapy | Lapatinib | Ado-trastuzumab emtansine | Trastuzumab | Cancer | HER-2/NEU EXPRESSION | UROTHELIAL BLADDER-CANCER | KINASE DOMAIN | CELL LUNG-CANCER | GROWTH-FACTOR RECEPTOR | PHASE-II TRIAL | SALIVARY DUCT CARCINOMA | ONCOLOGY | METASTATIC BREAST-CANCER | AFATINIB BIBW 2992 | GENE AMPLIFICATION | Neoplasms - metabolism | Up-Regulation | Receptor, ErbB-2 - genetics | Humans | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Male | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Maytansine - pharmacology | Breast Neoplasms - metabolism | Peritoneal Neoplasms - drug therapy | Uterine Cervical Neoplasms - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Adult | Female | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Peritoneal Neoplasms - secondary | Antibodies, Monoclonal, Humanized - therapeutic use | Maytansine - analogs & derivatives | Uterine Cervical Neoplasms - drug therapy | Clinical Trials as Topic | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Animals | Gene Amplification | Quinazolines - therapeutic use | Peritoneal Neoplasms - metabolism | Protein Kinase Inhibitors - pharmacology | Mutation | Quinazolines - pharmacology | Care and treatment | Biological products | Epidermal growth factor | Lung cancer, Non-small cell | Health aspects
Journal Article
Journal Article
Journal Article
Gynecologic oncology, ISSN 0090-8258, 2014, Volume 135, Issue 2, pp. 231 - 238
...). Methods A retrospective analysis was done of outcomes of patients with stage IB-IVA cervical cancer treated with primary radiation therapy with curative intent between 2000 and 2012... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Image-guided brachytherapy | GEC–ESTRO guidelines | Primary chemoradiation | Radiotherapy | Survival | Cervical cancer | GEC-ESTRO guidelines | TANDEM-OVOID APPLICATORS | PARAMETERS | INTRACAVITARY BRACHYTHERAPY | INTERSTITIAL BRACHYTHERAPY | ADAPTIVE BRACHYTHERAPY | OBSTETRICS & GYNECOLOGY | VIENNA APPLICATOR | PDR BRACHYTHERAPY | ONCOLOGY | RECOMMENDATIONS | PROGNOSTIC-FACTOR ANALYSES | Adenocarcinoma - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Adenosquamous - drug therapy | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Carcinoma, Squamous Cell - radiotherapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Imaging, Three-Dimensional | Adenocarcinoma - radiotherapy | Carcinoma, Adenosquamous - pathology | Uterine Cervical Neoplasms - radiotherapy | Brachytherapy - methods | Neoplasm Recurrence, Local | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Carcinoma, Adenosquamous - radiotherapy | Disease-Free Survival | Magnetic Resonance Imaging | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Radiotherapy, Image-Guided - methods | Aged | Neoplasm Staging | Cancer patients | Care and treatment | Radioisotope brachytherapy | Comparative analysis | Patient outcomes
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2013, Volume 130, Issue 1, pp. 75 - 80
Abstract Objective Cervical and vaginal cancers have virally-mediated or mutated defects in DNA damage repair responses, making these cancers sensible targets for ribonucleotide reductase inhibition... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Ribonucleotide reductase | Radiosensitization | Cervical cancer | Triapine | CONCURRENT CISPLATIN | GYNECOLOGIC-ONCOLOGY-GROUP | DNA-DAMAGE | CHEMOTHERAPY | RADIATION-THERAPY | OBSTETRICS & GYNECOLOGY | F-18-FDG PET | ONCOLOGY | PELVIC IRRADIATION | PHASE-I | IVA CARCINOMA | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Tomography, X-Ray Computed | Uterine Cervical Neoplasms - pathology | Positron-Emission Tomography | Thiosemicarbazones - administration & dosage | Vaginal Neoplasms - drug therapy | Chemoradiotherapy | Cisplatin - administration & dosage | Pyridines - adverse effects | Multimodal Imaging - methods | Adult | Female | Brachytherapy | Vaginal Neoplasms - radiotherapy | Pyridines - administration & dosage | Uterine Cervical Neoplasms - radiotherapy | Drug Administration Schedule | Vaginal Neoplasms - pathology | Uterine Cervical Neoplasms - drug therapy | Vaginal Neoplasms - diagnostic imaging | Thiosemicarbazones - adverse effects | Cisplatin - adverse effects | Fluorodeoxyglucose F18 | Uterine Cervical Neoplasms - diagnostic imaging | Aged | Neoplasm Staging | Index Medicus | ribonucleotide reductase | cervical cancer | radiosensitization
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2014, Volume 135, Issue 2, pp. 239 - 243
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2004, Volume 22, Issue 5, pp. 872 - 880
Journal Article